| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| João P M Messias, José R Paula, Alexandra S Grutter, Redouan Bshary, Marta C Soare. Dopamine disruption increases negotiation for cooperative interactions in a fish. Scientific reports. vol 6. 2017-01-02. PMID:26853241. |
the dopaminergic system plays a key role in this assessment: for instance, a decrease in dopamine transmission, which is signalled by the failure of an expected reward, may elicit a distinct behavioural response. |
2017-01-02 |
2023-08-13 |
Not clear |
| Georg Jucke. Inhibition of the reward system by antipsychotic treatment. Dialogues in clinical neuroscience. vol 18. issue 1. 2017-01-02. PMID:27069385. |
the mesolimbic dopaminergic reward system is responsible for the negative affective symptomatology of schizophrenia, which may be related to a low dopamine tonus within the ventral striatum. |
2017-01-02 |
2023-08-13 |
Not clear |
| Hongyoon Choi, Gi Jeong Cheon, Han-Joon Kim, Seung Hong Choi, Yong-Il Kim, Keon Wook Kang, June-Key Chung, E Edmund Kim, Dong Soo Le. Gray matter correlates of dopaminergic degeneration in Parkinson's disease: A hybrid PET/MR study using (18) F-FP-CIT. Human brain mapping. vol 37. issue 5. 2016-12-30. PMID:26846350. |
to measure dopaminergic degeneration in pd, binding ratio (br) of dopamine transporter in striatum was evaluated by (18) f-fp-cit. |
2016-12-30 |
2023-08-13 |
Not clear |
| S Orvokki Mattila, Jussi T Tuusa, Ulla E Petäjä-Rep. The Parkinson's-disease-associated receptor GPR37 undergoes metalloproteinase-mediated N-terminal cleavage and ectodomain shedding. Journal of cell science. vol 129. issue 7. 2016-12-30. PMID:26869225. |
the g-protein-coupled receptor 37 ( gpr37) has been implicated in the juvenile form of parkinson's disease, in dopamine signalling and in the survival of dopaminergic cells in animal models. |
2016-12-30 |
2023-08-13 |
human |
| Glenn M Dallérac, Damian M Cummings, Mark C Hirst, Austen J Milnerwood, Kerry P S J Murph. Changes in Dopamine Signalling Do Not Underlie Aberrant Hippocampal Plasticity in a Mouse Model of Huntington's Disease. Neuromolecular medicine. vol 18. issue 1. 2016-12-28. PMID:26782175. |
however, the direction of change and the lack of effect of dopaminergic pharmacological agents on synaptic function demonstrate that the perturbations are heterogeneous and region-specific, a finding that may explain the mixed results of dopamine therapy in hd. |
2016-12-28 |
2023-08-13 |
mouse |
| Karin Foerde, Bernd Figner, Bradley B Doll, Isabel C Woyke, Erin Kendall Braun, Elke U Weber, Daphna Shoham. Dopamine Modulation of Intertemporal Decision-making: Evidence from Parkinson Disease. Journal of cognitive neuroscience. vol 28. issue 5. 2016-12-26. PMID:26836514. |
to assess the role of dopamine in intertemporal decisions, we tested parkinson disease patients who suffer from dopamine depletion in the striatum, in either high (on medication, pdon) or low (off medication, pdoff) dopaminergic states. |
2016-12-26 |
2023-08-13 |
Not clear |
| Karin Foerde, Bernd Figner, Bradley B Doll, Isabel C Woyke, Erin Kendall Braun, Elke U Weber, Daphna Shoham. Dopamine Modulation of Intertemporal Decision-making: Evidence from Parkinson Disease. Journal of cognitive neuroscience. vol 28. issue 5. 2016-12-26. PMID:26836514. |
furthermore, reduced discounting in the high dopaminergic state was robust across multiple measures, providing new evidence for dopamine's role in making decisions about the future. |
2016-12-26 |
2023-08-13 |
Not clear |
| Hai-Hui Zhou, Dan-Lian Wu, Li-Yan Gao, Yun Fang, Wei-Hong G. L-Tetrahydropalmatine alleviates mechanical hyperalgesia in models of chronic inflammatory and neuropathic pain in mice. Neuroreport. vol 27. issue 7. 2016-12-20. PMID:26981712. |
these findings suggest that l-thp may ameliorate mechanical hyperalgesia by enhancing dopamine d1 receptor-mediated dopaminergic transmission. |
2016-12-20 |
2023-08-13 |
mouse |
| Dawei Qi, Qian Zhang, Wanhong Zhou, Jingjing Zhao, Bo Zhang, Yunfei Sha, Zhiqing Pan. Quantification of Dopamine in Brain Microdialysates with High-Performance Liquid Chromatography-Tandem Mass Spectrometry. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. vol 32. issue 4. 2016-12-20. PMID:27063714. |
the dopamine level in the brain and the mesolimbick dopaminergic system are responsible for nicotine addiction. |
2016-12-20 |
2023-08-13 |
rat |
| Larisa Tratnjek, Gordana Glavan, Tanja Višnjar, Marko Živi. Upregulation and axonal transport of synaptotagmin-IV in the direct-pathway medium spiny neurons in hemi-parkinsonian rats induced by dopamine D1 receptor stimulation. The European journal of neuroscience. vol 43. issue 7. 2016-12-19. PMID:26750488. |
in the hemi-parkinsonian rats with unilateral lesions of dopaminergic nigrostriatal neurons syt-iv and substance-p (sp) mrnas could be upregulated within the dopaminergically hypersensitive striatum of the lesioned brain hemisphere via the stimulation of striatal dopamine d1 (d1-r), but not d2 receptors. |
2016-12-19 |
2023-08-13 |
rat |
| Gessynger Morais-Silva, Mariane Ferreira-Santos, Marcelo T Mari. Conessine, an H3 receptor antagonist, alters behavioral and neurochemical effects of ethanol in mice. Behavioural brain research. vol 305. 2016-12-16. PMID:26924015. |
the blockade of h3 receptors and ethanol seem to interact in the modulation of dopaminergic neurotransmission of nigrostriatal pathway, decreasing dopamine metabolites in substantia nigra. |
2016-12-16 |
2023-08-13 |
mouse |
| Fatemeh Noohi, Nate B Boyden, Youngbin Kwak, Jennifer Humfleet, Martijn L T M Müller, Nicolaas I Bohnen, Rachael D Seidle. Interactive effects of age and multi-gene profile on motor learning and sensorimotor adaptation. Neuropsychologia. vol 84. 2016-12-16. PMID:26926580. |
we selected three genetic polymorphisms: catechol-o-methyl transferase (comt val158met) and dopamine d2 receptor (drd2 g>t), which are involved with dopaminergic regulation, and brain derived neurotrophic factor (bdnf val66met) that modulates neuroplasticity and has been shown to interact with dopaminergic genes. |
2016-12-16 |
2023-08-13 |
Not clear |
| Perla Moreno-Castilla, Luis F Rodriguez-Duran, Kioko Guzman-Ramos, Alejandro Barcenas-Femat, Martha L Escobar, Federico Bermudez-Ratton. Dopaminergic neurotransmission dysfunction induced by amyloid-β transforms cortical long-term potentiation into long-term depression and produces memory impairment. Neurobiology of aging. vol 41. 2016-12-15. PMID:27103531. |
although dopamine is a key modulator of synaptic plasticity, dopaminergic neurotransmission dysfunction in ad has mostly been associated to noncognitive symptoms. |
2016-12-15 |
2023-08-13 |
mouse |
| Stefania Fiore, Lidia Persichino, Sabrina Anticoli, Maria Francesca De Pandi. A neuroleptic malignant-like syndrome (NMLS) in a patient with Parkinson's disease resolved with rotigotine: a case report. Acta bio-medica : Atenei Parmensis. vol 85. issue 3. 2016-12-13. PMID:25567468. |
here, we describe the case of a 79 years old woman, with 19 years history of parkinson disease treated with l-dopa, dopamine agonists and mao inhibitors, whose sudden withdrawal due to lack of therapeutic compliance, led to sudden onset of high fever, muscle rigidity, akinesia, autonomic dysfunction, impaired level of consciousness, respiratory distress and dysphagia with inability to take oral dopaminergic therapy. |
2016-12-13 |
2023-08-13 |
Not clear |
| Ansley Grimes Stanfill, Yvette Conley, Ann Cashion, Carol Thompson, Ramin Homayouni, Patricia Cowan, Donna Hathawa. Neurogenetic and Neuroimaging Evidence for a Conceptual Model of Dopaminergic Contributions to Obesity. Biological research for nursing. vol 17. issue 4. 2016-12-13. PMID:25576324. |
pubmed, google scholar, and cumulative index to nursing and allied health literature searches were conducted with the search terms dopamine, obesity, weight gain, food addiction, brain regions relevant to the mesocortical and mesolimbic (reward) pathways, and relevant dopaminergic genes and receptors. |
2016-12-13 |
2023-08-13 |
Not clear |
| E Oikonomou, Th Paparrigopoulo. [Neuropsychiatric manifestations in Parkinson's disease]. Psychiatrike = Psychiatriki. vol 26. issue 2. 2016-12-13. PMID:26197101. |
dopaminergic medication may precipitate neuropsychiatric conditions, such as the dopamine dysregulation syndrome. |
2016-12-13 |
2023-08-13 |
Not clear |
| Elena Ivanova, Christopher W Yee, Botir T Sagdullae. Disruption in dopaminergic innervation during photoreceptor degeneration. The Journal of comparative neurology. vol 524. issue 6. 2016-12-13. PMID:26356010. |
dopaminergic amacrine cells (dacs) release dopamine in response to light-driven synaptic inputs, and are critical to retinal light adaptation. |
2016-12-13 |
2023-08-13 |
mouse |
| Shuai Zhang, Si-Yuan Shao, Xiu-Yun Song, Cong-Yuan Xia, Ya-Nan Yang, Pei-Cheng Zhang, Nai-Hong Che. Protective effects of Forsythia suspense extract with antioxidant and anti-inflammatory properties in a model of rotenone induced neurotoxicity. Neurotoxicology. vol 52. 2016-12-13. PMID:26408940. |
gavage administration of fs8 (50 and 200mg/kg, but not 10mg/kg) for 25 days significantly improved the behavior function, decreased the loss of dopaminergic neurons in substantia nigra (sn), and maintained the level of dopamine in striatum after unilateral infusion of rotenone in sn. |
2016-12-13 |
2023-08-13 |
Not clear |
| Su-Ping Peng, Sjef Copra. Comparison of Human Primary with Human iPS Cell-Derived Dopaminergic Neuron Grafts in the Rat Model for Parkinson's Disease. Stem cell reviews and reports. vol 12. issue 1. 2016-12-13. PMID:26438376. |
grafts of foetal ventral mesencephalic (vm) dopaminergic (da) neurons into the striatum have been shown to be able to restore striatal dopamine levels and to improve overall pd symptoms. |
2016-12-13 |
2023-08-13 |
human |
| Elena Marchesi, Anna Negrotti, Monica Angelini, Matteo Goldoni, Giorgia Abrignani, Stefano Calzett. A prospective study of the cumulative incidence and course of restless legs syndrome in de novo patients with Parkinson's disease during chronic dopaminergic therapy. Journal of neurology. vol 263. issue 3. 2016-12-13. PMID:26566909. |
it is hypothesized that the remittent course could be due to long-term adaptation (downregulation) of the hypersensitive post-synaptic dopamine receptors in the spinal cord to a continuous dopaminergic stimulation, possibly coupled with compensatory up-regulation of pre-synaptic dopamine re-uptake mechanism, in the patients in which the hypothalamic a11 area, site of origin of the dopamine-mediated diencephalo-spinal pathway, is involved in the neurodegenerative process. |
2016-12-13 |
2023-08-13 |
Not clear |